Literature DB >> 3875039

Isolation of a new human oncogene from a diffuse B-cell lymphoma.

A Eva, S A Aaronson.   

Abstract

Utilizing DNA transfection analysis with the continuous NIH 3T3 cell line as assay cell, we and other have observed that as many as 10-50% of human haematopoietic tumours contain oncogenes, the vast majority of which are members of the ras proto-oncogene family. In addition, Cooper and co-workers have reported the detection and isolation of specific oncogenes, B-lym and T-lym, which appear to be activated in human and rodent tumours of certain B and T lymphoid cells, respectively. In surveying human haematopoietic malignancies, we observed that DNA of a primary human diffuse B-cell lymphoma induced an unusual transformed focus on transfection of NIH 3T3 cells. Here, we report the molecular cloning and physical characterization of this human oncogene, whose transforming activity was shown to reside within a human DNA sequence of 45 kilobases (kb) cloned in a cosmid vector. Its properties distinguish it from previously reported retroviral or nonretroviral oncogenes.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3875039     DOI: 10.1038/316273a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  53 in total

1.  A crystallographic view of interactions between Dbs and Cdc42: PH domain-assisted guanine nucleotide exchange.

Authors:  Kent L Rossman; David K Worthylake; Jason T Snyder; David P Siderovski; Sharon L Campbell; John Sondek
Journal:  EMBO J       Date:  2002-03-15       Impact factor: 11.598

2.  Loss of the amino-terminal helix-loop-helix domain of the vav proto-oncogene activates its transforming potential.

Authors:  S Katzav; J L Cleveland; H E Heslop; D Pulido
Journal:  Mol Cell Biol       Date:  1991-04       Impact factor: 4.272

3.  Structure and transforming potential of the human cot oncogene encoding a putative protein kinase.

Authors:  J Miyoshi; T Higashi; H Mukai; T Ohuchi; T Kakunaga
Journal:  Mol Cell Biol       Date:  1991-08       Impact factor: 4.272

4.  N-terminal Dbl domain of the RhoGEF, Kalirin.

Authors:  Vitaliy Y Gorbatyuk; Martin R Schiller; Oksana I Gorbatyuk; Marek Barwinski; Jeffrey C Hoch
Journal:  J Biomol NMR       Date:  2012-03       Impact factor: 2.835

Review 5.  Inhibition of Cdc42 and Rac1 activities in pheochromocytoma, the adrenal medulla tumor.

Authors:  Pauline Croisé; Laurent Brunaud; Petra Tóth; Stéphane Gasman; Stéphane Ory
Journal:  Small GTPases       Date:  2016-06-29

6.  Regulation of proto-oncogenic dbl by chaperone-controlled, ubiquitin-mediated degradation.

Authors:  Elena Kamynina; Krista Kauppinen; Faping Duan; Nora Muakkassa; Danny Manor
Journal:  Mol Cell Biol       Date:  2006-12-18       Impact factor: 4.272

7.  Rho-guanine nucleotide exchange factors during development: Force is nothing without control.

Authors:  Shai Mulinari; Udo Häcker
Journal:  Small GTPases       Date:  2010-07

Review 8.  Cdc42 in oncogenic transformation, invasion, and tumorigenesis.

Authors:  Kristy Stengel; Yi Zheng
Journal:  Cell Signal       Date:  2011-04-16       Impact factor: 4.315

9.  Transformation by Rho exchange factor oncogenes is mediated by activation of an integrin-dependent pathway.

Authors:  M A Schwartz; D Toksoz; R Khosravi-Far
Journal:  EMBO J       Date:  1996-12-02       Impact factor: 11.598

10.  Phosphorylation-dependent and constitutive activation of Rho proteins by wild-type and oncogenic Vav-2.

Authors:  K E Schuebel; N Movilla; J L Rosa; X R Bustelo
Journal:  EMBO J       Date:  1998-11-16       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.